Francisco Bermúdez to Humans
This is a "connection" page, showing publications Francisco Bermúdez has written about Humans.
Connection Strength
0.052
-
Mesas C, Garc?s V, Mart?nez R, Ortiz R, Doello K, Dominguez-Vera JM, Berm?dez F, Porres JM, L?pez-Jurado M, Melguizo C, Delgado-L?pez JM, Prados J. Colon cancer therapy with calcium phosphate nanoparticles loading bioactive compounds from Euphorbia lathyris: In vitro and in vivo assay. Biomed Pharmacother. 2022 Nov; 155:113723.
Score: 0.010
-
Mesas C, Mart?nez R, Doello K, Ortiz R, L?pez-Jurado M, Berm?dez F, Qui?onero F, Prados J, Porres JM, Melguizo C. In vivo antitumor activity of Euphorbia lathyris ethanol extract in colon cancer models. Biomed Pharmacother. 2022 May; 149:112883.
Score: 0.010
-
Olalde I, Mallick S, Patterson N, Rohland N, Villalba-Mouco V, Silva M, Dulias K, Edwards CJ, Gandini F, Pala M, Soares P, Ferrando-Bernal M, Adamski N, Broomandkhoshbacht N, Cheronet O, Culleton BJ, Fernandes D, Lawson AM, Mah M, Oppenheimer J, Stewardson K, Zhang Z, Jim?nez Arenas JM, Toro Moyano IJ, Salazar-Garc?a DC, Castanyer P, Santos M, Tremoleda J, Lozano M, Garc?a Borja P, Fern?ndez-Eraso J, Mujika-Alustiza JA, Barroso C, Berm?dez FJ, Viguera M?nguez E, Burch J, Coromina N, Viv? D, Cebri? A, Fullola JM, Garc?a-Puchol O, Morales JI, Oms FX, Maj? T, Verg?s JM, D?az-Carvajal A, Ollich-Castanyer I, L?pez-Cachero FJ, Silva AM, Alonso-Fern?ndez C, Delibes de Castro G, Jim?nez Echevarr?a J, Moreno-M?rquez A, Pascual Berlanga G, Ramos-Garc?a P, Ramos-Mu?oz J, Vijande Vila E, Aguilella Arzo G, Esparza Arroyo ?, Lillios KT, Mack J, Velasco-V?zquez J, Waterman A, Ben?tez de Lugo Enrich L, Benito S?nchez M, Agust? B, Codina F, de Prado G, Estalrrich A, Fern?ndez Flores ?, Finlayson C, Finlayson G, Finlayson S, Giles-Guzm?n F, Rosas A, Barciela Gonz?lez V, Garc?a Ati?nzar G, Hern?ndez P?rez MS, Llanos A, Carri?n Marco Y, Collado Beneyto I, L?pez-Serrano D, Sanz Tormo M, Valera AC, Blasco C, Liesau C, R?os P, Daura J, de Pedro Mich? MJ, Diez-Castillo AA, Flores Fern?ndez R, Franc?s Farr? J, Garrido-Pena R, Gon?alves VS, Guerra-Doce E, Herrero-Corral AM, Juan-Cabanilles J, L?pez-Reyes D, McClure SB, Merino P?rez M, Oliver Foix A, Sanz Borr?s M, Sousa AC, Vidal Encinas JM, Kennett DJ, Richards MB, Werner Alt K, Haak W, Pinhasi R, Lalueza-Fox C, Reich D. The genomic history of the Iberian Peninsula over the past 8000 years. Science. 2019 03 15; 363(6432):1230-1234.
Score: 0.008
-
Su?rez E, Gonz?lez L, D?az-Toro EC, Calo WA, Berm?dez F, Ortiz AP. Incidence of oral cavity and pharyngeal cancers by anatomical sites in population-based registries in Puerto Rico and the United States of America. P R Health Sci J. 2013 Dec; 32(4):175-81.
Score: 0.005
-
Schussel J, Zhou XC, Zhang Z, Pattani K, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Brait M, Li R, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res. 2013 Jun 15; 19(12):3268-75.
Score: 0.005
-
Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, Sidransky D, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila). 2010 Sep; 3(9):1093-103.
Score: 0.004
-
Alonso L, Berm?dez F, Abarca M, Garc?a Almeida JM. [Improving diagnosis? New sap for an old tree]. Med Clin (Barc). 2011 Nov 12; 137(12):561-4.
Score: 0.004
-
Gavil?n JC, Berm?dez F, Romero M, Gonz?lez Santos P. [Levetiracetam hepatitis]. Med Clin (Barc). 2004 Jan 17; 122(1):38.
Score: 0.003
-
Gavil?n JC, Berm?dez FJ, Belmonte A, Gonz?lez-Santos P. [Niacin-induced hepatitis]. Med Clin (Barc). 2002 Apr 20; 118(14):558.
Score: 0.002